Stepwise dose escalation, corticosteroid premedication as well as tocilizumab (anti-IL-6 mAb) administration in the early onset of CRS are effective and significantly reduce the number of grade ≥3 AEs [86]. Here, IL6 is linked to congenital rubella syndrome.